Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma

Cancer Genetics and Cytogenetics

Volumn 111, Issue 1, 1999, Pages 92-98

  Espinet, Blanca ^a   Solé, Francesc ^a   Woessner, Soledad ^a   Bosch, Francesc ^b   Florensa, Lourdes ^a   Campo, Elies ^b   Costa, Dolors ^b   Lloveras, Elisabet ^a   Vilà, Rosa M ^a   Besses, Carles ^a   Montserrat, Emili ^b   Sans Sabrafen, Jordi ^a  

^a Laboratori de Citol Hematologica   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD23 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; PHORBOL 12 ACETATE 13 MYRISTATE; PHYTOHEMAGGLUTININ;

ADULT; AGED; ARTICLE; CHROMOSOME 1; CHROMOSOME 13; CHROMOSOME 17; CHROMOSOME 2; CHROMOSOME 21; CHROMOSOME 9; CHROMOSOME ANALYSIS; CHROMOSOME LOSS; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MANTLE CELL LYMPHOMA; MONOSOMY; PRIORITY JOURNAL; TRISOMY; Y CHROMOSOME;

EID: 0032907340     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00228-3     Document Type: Article

References (42)

1. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K.C., Grogan T.M., Isaacson P.G., Knowles D.M., Mason D.Y., Müller-Hermelink H.K., Pileri S.A., Piris M.A., Ralfkiaer E., Warnke R.A. A revised European-American Classification of lymphoid neoplasms. a proposal from the International Lymphoma Study Group Blood. 84:1994;1361-1392.
2. Gerard-Marchant R., Hamlin I., Lennert K., Rilke F., Stansfeld A.G., Van Unnik J.A.M. Classification of non-Hodgkin's lymphomas. Lancet. 2:1974;405-406.
3. Lennert K. Malignant Lymphomas Other than Hodgkin's Disease. 1978;Springer-Verlag, New York.
4. Stansfeld A., Diebold J., Kapancy Y., Keleny G., Lennert K., Mioduszewska O., Noel H., Rilke F., Sundstrom C., van Unnik J., Wright D. Updated Kiel classification for lymphomas. Lancet. 1:1988;292-293.
5. Lennert K., Feller A. Histopathology of Non-Hodgkin's Lymphoma. 2nd Ed:1992;Springer-Verlag, New York.
6. Berard C.W., Jaffe E.S., Braylan R.C., Mann R.B., Nanba K. Immunologic aspects and pathology of the malignant lymphomas. Cancer. 42:1978;911-924.
7. Rosenberg S.A. NCI sponsored study of the classification of non-Hodgkin lymphoma. summary and description of a working formulation for clinical usage Cancer. 49:1982;2112-2135.
8. Bennet M.H., Farrer-Brown G., Henry K., Jellife A.M. Classification of non-Hodgkin's lymphomas. Lancet ii: 405-406:1974.
9. Van den Berghe E., de Wolf-Peeters C., van den Oord J.J., Wlodarska I., Delabie J., Stul M., Thomas J., Michaux J.L., Mecucci C., Cassiman J.J., Van den Berghe H. Translocation (11;14). a cytogenetic anomaly associated with B cell lymphomas of non-follicle centre cell lineage J Pathol. 163:1991;13-18.
10. Pittaluga S., Wlodarska I., Stul M., Thomas J., Verhoef G., Cassiman J.J., Van den Berghe H., De Wolf-Peeters C. Mantle cell lymphoma. a clinico-pathological study of 55 cases Histopathology. 26:1995;17-24.
11. Zucca E., Roggero E., Pinotti C., Cappella C., Venco A., Cavalli F. Patterns of survival in mantle cell lymphoma. Ann Oncol. 6:1995;257-262.
12. Van den Berghe E., De Wolf-Peeters C., Vaughan Hudson G., Vaughan Hudson B., Pittaluga S., Anderson L., Linch D.C. The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non-intensive therapy by the British National Lymphoma Investigation Group. Br J Haematol. 99:1997;842-847.
13. Brito-Babapulle V., Ellis J., Matutes E., Oscier D., Khokhar T., MacLennan K., Catovsky D. Translocation t(11;14)(q13;q32) in chronic lymphoid disorders. Genes Chromosom Cancer. 5:1992;158-165.
14. Johansson B., Mertens F., Mitelman F. Cytogenetic evolution patterns in non-Hodgkin's lymphoma. Blood. 86:1995;3905-3914.
15. Argatoff L.H., Connors J.M., Klasa R.J., Horsman D.E., Gascoyne R.D. Mantle cell lymphoma. a clinicopathologic study of 80 cases Blood. 89:1997;2067-2078.
16. Decaudin D., Bosq J., Munck J.-N., Bayle C., Koscielny S., Boudjemaa S., Bennaceur A., Venuat A.-M., Naccache P., Bendahmane B., Ribrag V., Carde P., Pico J.L., Hayat M. Mantle cell lymphomas. characteristics, natural history and prognostic factors of 45 cases Leuk Lymphoma. 26:1997;539-550.
17. Van den Berghe H., Parloir C., David G., Michaux J.L., Sokal M. A new characteristic karyotypic anomaly in lymphoproliferative disorders. Cancer. 44:1979;188-195.
18. Leroux D., Le Marc'hadour F., Gressin R., Jacob M.C., Keddari E., Monteil M., Caillot P., Jalbert P., Sotto J.J. Non-Hodgkin's lymphomas with t(11;14)(q13;q32). a subset of mantle zone/intermediate lymphocytic lymphoma? Br J Haematol. 77:1991;346-353.
19. Medeiros L.J., Van Krieken J.H., Jaffe E.S., Raffeld M. Association of bcl1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood. 76:1990;2086-2090.
20. Matsushime H., Roussel M.F., Ashmun R.A., Sherr C.J. Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell. 65:1991;701-713.
21. Raffeld M., Jaffe E.S. bcl-1, t(11;14) and mantle cell-derived lymphomas. Blood. 78:1991;259-263.
22. Bosch F., Jares P., Campo E., Lopez-Guillermo A., Piris M.A., Villamor N., Tassies D., Jaffe E.S., Montserrat E., Rozman C., Cardesa A. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders. a highly specific marker of mantle cell lymphoma Blood. 84:1994;2726-2732.
23. Komatsu H., Yoshida K., Seto M., Iida S., Aikawa T., Ueda R., Mikuni C. Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation. Br J Haematol. 85:1993;427-429.
24. Solé F., Woessner S. Microwaves improve chromosome G banding in fresh blood and bone marrow. J Clin Pathol. 45:1992;1118.
25. ISCN (1995): Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel.
26. Pérez Losada A., Wessman M., Tiainen M., Hopman A., Willard H.F., Solé F., Caballín M.R., Woessner S., Knuutila S. Trisomy 12 in chronic lymphocytic leukemia. an interphase cytogenetic study Blood. 78:1991;775-779.
27. Williams M.E., Swerdlow S.H. Cyclin D1 overexpression in non-Hodgkin's lymphoma with chromosome 11 bcl-1 rearrangement. Ann Oncol. 5(suppl 1):1994;S71.
28. de Boer C.J., Loyson S., Kliun P.M., Kluin-Nelemans C., Schuring E., van Krieken H.J.M. Multiple breakpoints within the Bcl-1 locus in B-cell lymphoma. rearrangements of the cyclin D1 gene Cancer Res. 53:1993;4148-4152.
29. Rimokh R., Berger F., Delsol G., Charrin C., Bertheas M.F., Ffrench M., Garoscio M., Felman P., Coiffier B., Bryon P.A., Rochet M., Gentilhomme O., Germain D., Magaud J.P. Rearrangements and overexpression of the Bcl-1/PRAD-1 gene in intermediate lymphocytic lymphoma and in the t(11q13)-bearing leukemias. Blood. 81:1993;3063-3067.
30. Ott M., Ott G., Kuse R., Porowski P., Gunzer U., Feller A.C., Müller-Hermelink H.K. The anaplastic variant of centrocytic lymphoma is marked by frequent rearrangements of the bcl-1 gene and high proliferation indices. Histopathology. 24:1994;329-334.
31. Ott G., Kalla J., Ott M., Schryen B., Katzenberger T., Müller J.G., Müller-Hermelink H.K. Blastoid variants of mantle cell lymphoma. frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones Blood. 89:1997;1421-1429.
32. Mitelman F., Levan G. Clustering of aberrations to specific chromosomes in human neoplasms. IV. A survey of 1871 cases. Hereditas. 95:1981;79-139.
33. Hernández J.M., Mecucci C., Michaux L., Criel A., Stul M., Meeus P. del(7q) in chronic-B cell lymphoproliferative disorders. del(7)(q32) Cancer Genet Cytogenet. 93:1997;147-152.
34. Solé F., Woessner S., Florensa L., Montero S., Asensio A., Besses C., Sans-Sabrafen J. A new chromosomal anomaly associated with mature B-cell chronic-lymphoproliferative disorders. del(7)(q32) Cancer Genet Cytogenet. 64:1993;170-172.
35. Solé F., Woessner S., Florensa L., Espinet B., Mollejo M., Martín P., Piris M.A. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma. Br J Haematol. 98:1997;446-449.
36. Hernández L., Fest T., Cazorla M., Teruya-Feldstein J., Bosch F., Peinado M.A., Piris M.A., Montserrat E., Cardesa A., Jaffe E.S., Campo E., Raffelt M. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood. 87:1996;3351-3359.
37. Zoldan M.C., Inghirami G., Masuda Y., Vandekerckhove F., Raphael B., Amorosi E., Hymes K., Frisera G. Large-cell variants of mantle cell lymphoma. cytologic characteristics and p53 anomalies may predict poor outcome Br J Haematol. 93:1996;475-486.
38. Jares P., Campo E., Pinyol M., Bosch F., Miquel R., Fernandez P.L., Sanchez-Beato M., Solé F., Pérez-Losada A., Nayach I., Mallofre C., Piris M.A., Montserrat E., Cardesa A. Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity. Am J Pathol. 148:1996;1591-1600.
39. Monteil M., Callan M., Dascalescu C., Sotto J.J., Leroux D. Molecular diagnosis of t(11;14) in mantle cell lymphoma using two colour interphase fluorescence in situ hybridization. Br J Haematol. 93:1996;656-660.
40. Takashima T., Itoh M., Ueda Y., Nishida K., Tamaki T., Misawa S., Abe T., Seto M., Machii T., Taniwaki M. Detection of 14q32.33 translocation and t(11;14) in interphase nuclei of chronic B-cell leukemia/lymphomas by in situ hybridization. Int J Cancer. 72:1997;31-38.
41. Veldman T., Vignon C., Schrock E., Rolwey J.D., Ried T. Hidden chromosome abnormalities in haematological malignancies detected by multicolor spectral karyotyping. Nature Genet. 15:1997;406-410.
42. Houldworth J., Chaganti R.S.K. Comparative genomic hybridization. an overview Am J Pathol. 145:1994;1253-1256.